Evidence map›Paper›PMID 34638850›Full record

ArticleInternational journal of molecular sciences2021

Opportunities and Pitfalls of Fluorescent Labeling Methodologies for Extracellular Vesicle Profiling on High-Resolution Single-Particle Platforms.

Diogo Fortunato, Danilo Mladenović, Mattia Criscuoli, Francesca Loria, Kadi-Liis Veiman, Davide Zocco, Kairi Koort, Natasa Zarovni

Erratum issuedAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Diogo FortunatoExosomics SpA, 53100 Siena, Italy.ORCID 0000-0003-2732-477X
Danilo MladenovićHansaBioMed Life Sciences Ltd., 12618 Tallinn, Estonia.ORCID 0000-0002-0877-2035
Mattia CriscuoliExosomics SpA, 53100 Siena, Italy.
Francesca LoriaHansaBioMed Life Sciences Ltd., 12618 Tallinn, Estonia.ORCID 0000-0003-1180-4883
Kadi-Liis VeimanHansaBioMed Life Sciences Ltd., 12618 Tallinn, Estonia.
Davide ZoccoExosomics SpA, 53100 Siena, Italy.
Kairi KoortSchool of Natural Sciences and Health, Tallinn University, 10120 Tallinn, Estonia.ORCID 0000-0001-7831-8973
Natasa ZarovniExosomics SpA, 53100 Siena, Italy.

Funding

European Union 722148European Union 765492
6 · The paper itself

Abstract

The relevance of extracellular vesicles (EVs) has grown exponentially, together with innovative basic research branches that feed medical and bioengineering applications. Such attraction has been fostered by the biological roles of EVs, as they carry biomolecules from any cell type to trigger systemic paracrine signaling or to dispose metabolism products. To fulfill their roles, EVs are transported through circulating biofluids, which can be exploited for the administration of therapeutic nanostructures or collected to intercept relevant EV-contained biomarkers. Despite their potential, EVs are ubiquitous and considerably heterogeneous. Therefore, it is fundamental to profile and identify subpopulations of interest. In this study, we optimized EV-labeling protocols on two different high-resolution single-particle platforms, the NanoFCM NanoAnalyzer (nFCM) and Particle Metrix ZetaView Fluorescence Nanoparticle Tracking Analyzer (F-NTA). In addition to the information obtained by particles' scattered light, purified and non-purified EVs from different cell sources were fluorescently stained with combinations of specific dyes and antibodies to facilitate their identification and characterization. Despite the validity and compatibility of EV-labeling strategies, they should be optimized for each platform. Since EVs can be easily confounded with similar-sized nanoparticles, it is imperative to control instrument settings and the specificity of staining protocols in order to conduct a rigorous and informative analysis.

Indexed as

FluorescenceExtracellular VesiclesFlow CytometryFluorescent DyesHEK293 CellsHT29 CellsHumansNanoparticlesNanotechnologyStaining and LabelingFluorescent Dyesantibodyexosomesextracellular vesiclesflow cytometryfluorescent dyesisolationnanoparticle tracking analysispurificationsubpopulationstetraspanin

Identifiers

PMID34638850
PMCPMC8508895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.